| Chiesi, Alberto (Chiesi 201409 President of Chiesi Group) |
President/Director/Head Business Group/Unit/Division |
Chiesi (Group) |
Italy |
| Chiesi, Paolo (Chiesi 201309 VP + RnD Director) |
Research & Development Manager |
Chiesi (Group) |
Italy |
| Cicchetti, Luca (Bio-Techne 201607– Managing Director Italy before Space Import-Export) |
Managing Director |
Bio-Techne (Group) |
Italy |
| Colli, Enrico (Bioxell –200711– CMO + Head of RnD) |
Chief Medical Officer (CMO) |
Cosmo Pharmaceuticals (Group) |
Italy |
| Conni, Mario (Eurofins 201410– Managing Director of Eurofins Genomics Srl) |
Managing Director |
Eurofins (Group) |
Italy |
| Corazza, Sabrina (Axxam 201603 Director Business Development) |
Business Development Manager / Strategy Manager |
Axxam S.p.A. |
Italy |
| Corcelli, Angela (Univ Bari 201303 Professor) |
Professor |
University of Bari (Università degli studi di Bari Aldo Moro) |
Italy |
| Curtis, Andrew (NMS Group 202208– Chief Strategy Officer before Artelus + GNS Healthcare + SUDA Pharma + Affimed) |
Business Development Manager / Strategy Manager |
NMS Group (Group) |
Italy |
| de Andrade, Gonçalo Rebelo (Indaco Venture 202403 Partner at Indaco Bio Fund) |
Partner (venture partner) |
Indaco Venture (Group) |
Italy |
| De Luca, Claudio (NanoPhoria 202205 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NanoPhoria (IT) |
Italy |
| Del Bono, Alessandro (Mediolanum 201612 CEO) |
Chief Executive Officer (CEO) |
Mediolanum (Group) |
Italy |
| Del Bono, Cristina (Mediolanum 201612 Licensing + Business Development Director) |
Business Development Manager / Strategy Manager |
Mediolanum (Group) |
Italy |
| di Condojanni, Sergio Marullo (Angelini 202403 CEO of Angelini Industries) |
Chief Executive Officer (CEO) |
Angelini (Group) |
Italy |
| Di Francesco, Ugo (Chiesi 201707 CEO) |
Chief Executive Officer (CEO) |
Chiesi (Group) |
Italy |
| Di Giorgio, Paolo (Angelini 202209 CEO + Managing Director of Angelini Ventures) |
Chief Executive Officer (CEO) |
Angelini (Group) |
Italy |
| Di Naro, Antonio Francesco (Adienne 201205 VEP + Founder) |
Chief Executive Officer (CEO) |
Adienne (Group) |
Italy |
| Di Terlizzi, Ines (DiaSorin 201607 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
DiaSorin (Group) |
Italy |
| Dionne, Dennis (Newron 201701– VP Commercial Affairs before JnJ + Novartis) |
Chief Commercial Officer (CCO) |
Newron (Group) |
Italy |
| Dolgos, Hugues (NMS Group 202208 CEO) |
Chief Executive Officer (CEO) |
NMS Group (Group) |
Italy |
| Dominici, Massimo (Univ Modena 202006 Professor + Scientific Founder of Rigenerand) |
Professor |
University of Modena |
Italy |
| Dompé, Sergio (Dompé 200807 President) |
n. a. |
Dompé (Group) |
Italy |
| Donadio, Stefano (Naicons Srl 201804 CEO before Biosearch Italia + Lepetit + Abbot Labs) |
Chief Executive Officer (CEO) |
Naicons S.r.l. |
Italy |
| Dotto, Marco (Health Catalyst 202001 Senior Consultant BusDev + Strategic Partnerships) |
Principal (venture capital) |
Angelini (Group) |
Italy |
| D’Addio, Francesca |
Professor |
Enthera S.r.l. (Enthera Pharmaceuticals) |
Italy |
| Ergun, Elcin Baker (Menarini 201909– CEO before Merck (DE) 201409 Head Global Commerical at Merck Serono) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Italy |
| Eros, Paul (DiaSorin 201607 VP International Marketing for DiaSorin Molecular) |
Sales Manager / Marketing Manager |
DiaSorin (Group) |
Italy |
| Faraco, Vincenza (University of Naples Federico II 201405) |
Researcher (university / research institute) |
University of Naples Federico II |
Italy |
| Fasanotti, Umberto Saini (DANI Instruments 201303 President) |
President/Director/Head Business Group/Unit/Division |
DANI Instruments (Group) |
Italy |
| Fava, Riccardo (DiaSorin 201607 IR + Corporate Communications Director) |
Public Relations Manager / Investor Relations Manager |
DiaSorin (Group) |
Italy |
| Ferro, Laura Iris (Gentium 200508 CEO) |
Chief Executive Officer (CEO) |
Jazz Pharmaceuticals (Group) |
Italy |
| Fiorentino, Francesco (Genoma srl 1998– CEO + Founder) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
Italy |
| Fornaroli, Micol (Bracco 201710 Chief Strategy Officer at Bracco Imaging SpA) |
Business Development Manager / Strategy Manager |
Bracco (Group) |
Italy |
| Frattini, Sergio (ASG Superconductors 202301 CEO) |
Chief Executive Officer (CEO) |
ASG Superconductors (Group) |
Italy |
| Fundarò, Paolo (Xgen Venture 202106– Managing Partner + Co-Founder & Genextra 200607 CEO) |
Chief Executive Officer (CEO) |
Genextra (Group) |
Italy |
| Galli, Roberto (Newron 202307– promoted to CFO before VP Finance) |
Chief Financial Officer (CFO) |
Newron (Group) |
Italy |
| Garotta, Gianni (Eporgen Venture 201211 Scientific Director) |
Board member, executive |
Eporgen Venture S.p.A. |
Italy |
| Gaspari, Gregorio (Italy (govt) 202203 Analyst at CDP Venture Capital Evolution Fund) |
Analyst (Financial / Industry) |
Italy (govt) |
Italy |
| Giardina, Giuseppe (Nikem Research 201201) |
n. a. |
Nikem Research S.r.l. |
Italy |
| Giorgi, Gianluca (Univ Siena 202211 Professor at Dept of Biotechnology, Chemistry + Pharmacy) |
Professor |
University of Siena |
Italy |
| Giorgini, Giuseppe (Silicon Biosystems 200601– CEO before Amgen Italy Managing Director) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Italy |
| Glueck, Reinhard (Etna Biotech 200612 CEO) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
Italy |
| Goretti, Letizia (Alia Therapeutics 202305– CEO before JnJ Innovation Centre London + BMS Italy) |
Chief Executive Officer (CEO) |
Alia Therapeutics S.r.l. |
Italy |
| Hafenbradl, Doris (Axxam 201411 VP Discovery Services) |
President/Director/Head Business Group/Unit/Division |
Axxam S.p.A. |
Italy |
| Haigh, Adrian (Gentium 201201 SVP Commercial Operations) |
Chief Commercial Officer (CCO) |
Jazz Pharmaceuticals (Group) |
Italy |
| Harbort, Diana (Cassiopea 201507 CEO) |
Chief Executive Officer (CEO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
| Holland, Yasemin (Coulter Partners 202205 Senior Research Associate at Milan Office before freelancer + Boyden ES) |
Human Resources Manager |
Coulter Partners (The Coulter Partnership Ltd.) |
Italy |
| Islam, Khalid (Gentium 200912– CEO before Arpida 199907–200805 CEO) |
Chief Executive Officer (CEO) |
Jazz Pharmaceuticals (Group) |
Italy |
| Jaworek, Michal (Approxima 202302 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Approxima S.r.l. |
Italy |
| Jumel, Pierre-Edouard (Diadem 202203 CFO) |
Chief Financial Officer (CFO) |
Diadem S.p.A. (Diadem Dx) |
Italy |
| Kalisz, Henryk M. (Enzymes4Biotech 201110– Founder before Eucodis Bioscience + Nerviano Medical Sciences + Pfizer Italy) |
Company Founder |
Enzymes4Biotech (Henryk M Kalisz) |
Italy |
| Katinov, Maxim (GFBiochemicals 201509 CEO) |
Chief Executive Officer (CEO) |
GFBiochemicals (Group) |
Italy |
| Keywood, Charlotte (Zambon 201603 Head RnD before Addex Pharma CMO) |
Research & Development Manager |
Zambon (Group) |
Italy |
| Khevenhueller Borghese, Camilla (IBI-Lorenzini 201609 CEO) |
Chief Executive Officer (CEO) |
Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (IBI-Lorenzini) |
Italy |
| Kinnon, Paul (Diadem 202010– CEO before PredictImmune + Transgenomic + ZyGEM + Invitrogen + Guava Technologies) |
Chief Executive Officer (CEO) |
Diadem S.p.A. (Diadem Dx) |
Italy |
| Köstlin, Ulrich (Newron 2013– Board Chairman before until 2011 Management Board Member of Bayer Schering Pharma AG) |
Board member, non-executive |
Newron (Group) |
Italy |
| Landi, Fabrizio (Panakés Partners 202107 Managing Partner + Co-Founder) |
Managing Partner (investment firm) |
Panakès Partners (Group) |
Italy |
| Lazzarin, Francesca (Coulter Partners 202205– Executive Director at Milan Office before Korn Ferry + Ken Clark) |
Human Resources Manager |
Coulter Partners (The Coulter Partnership Ltd.) |
Italy |
| Lehuu, Bertrand (BioXell 200703– CBO before 25y pharma industry incl Global Licensing Director at Roche in Basel) |
Chief Business Officer (CBO) |
Cosmo Pharmaceuticals (Group) |
Italy |
| Liberati, Chiara (Golgi Neurosciences 202308 CEO before Axxam 201107 Head of Discovery) |
Researcher (industry) |
Golgi Neurosciences S.r.l. |
Italy |
| Lohmer, Stefan (Axxam 200807 CEO) |
Chief Executive Officer (CEO) |
Axxam S.p.A. |
Italy |
| Lombardo, Angelo (San Raffaele 202006 Head of Gourp of Epigenetic Regulation + Targeted Genome Edigint at SR-Tiget) |
Researcher (university / research institute) |
San Raffaele of Monte Tabor Foundation |
Italy |
| Luchinat, Claudio (Univ Florence 201706 Professor + Co-Founder of Magnetic Resonance Center (CERM)) |
Professor |
University of Florence |
Italy |
| Maglione, Vincenzo (Farmaceutici Damor 202007 CEO + Managing Director) |
Chief Executive Officer (CEO) |
Farmaceutici Damor S.p.A. |
Italy |
| Magnini, Aldo (Cambrex 201903 Managing Director at Cambrex Milan) |
Managing Director |
Cambrex (Group) |
Italy |
| Mahnke, Lisa (NMS Group 202208 CMO of NMS Srl + Managing Director of NMS Inc) |
Chief Medical Officer (CMO) |
NMS Group (Group) |
Italy |
| Malizia, Andrea P. (IAMA Therapeutics 202203 CEO) |
Chief Executive Officer (CEO) |
Iama Therapeutics S.r.l. |
Italy |
| Manaresi, Nicolò (Silicon Biosystems 201105 CTO before CEO + co-founder) |
Chief Technology/Technical Officer (CTO) |
Menarini (Group) |
Italy |
| Maraschiello, Ciriaco (Evotec 202107 EVP Global Head of Drug Development + Head of Verona Site) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Italy |
| Marazzi, Fabio (Emmeplus 201404 Senior Managing Partner + Founder alos Professor at Bergamo University) |
Managing Partner |
Emmeplus S.r.l |
Italy |
| Mari, Giorgio (Rigenerand 202006 CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Italy |
| Marini, Luca (Xyence Capital 202205 CEO) |
Chief Executive Officer (CEO) |
Xyence Capital SGR |
Italy |
| Mazzoleni, Stefania (Genenta Science 202112 Media + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Genenta Science (Group) |
Italy |
| Mea, Marianna (Ecoreach srl 201409 Project Manager) |
n. a. |
Ecoreach s.r.l. |
Italy |
| Milioto, Giuliana (Coulter Partners 202205– Research Associate at Milan Office before Korn Ferry) |
Human Resources Manager |
Coulter Partners (The Coulter Partnership Ltd.) |
Italy |
| Misciattelli, Natalia (AAVantgarde Bio 202209– CEO before NovalGen + Freeline Tx + PA Consulting + GE Healthcare) |
Chief Executive Officer (CEO) |
AAVantgarde Bio S.r.l. |
Italy |
| Mondello, Luigi (Univ Messina 201412 Professor) |
Professor |
University of Messina (Università degli Studi di Messina) |
Italy |
| Moro, Luigi (Cassiopea 201509 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
| Naldini, Luigi (San Raffaele 201909 Director of SR-TIGET + Genenta Co-Founder) |
Professor |
San Raffaele of Monte Tabor Foundation |
Italy |
| Neecke, Holger |
n. a. |
Asahi Glass (AGC) (Group) |
Italy |
| Neri, Duccio (Philogen 201301 CEO) |
Chief Executive Officer (CEO) |
Philogen (Group) |
Italy |
| Nicosia, Alfredo (NousCom 201605–201905 CEO at NousCom Srl + Co-Founder before Okairos RETIRED 5/19) |
Chief Executive Officer (CEO) |
Nouscom (Group) |
Italy |
| Palmisano, Riccardo (InnovaVector 202210– before MolMed 201606 CEO) |
Chief Executive Officer (CEO) |
InnovaVector S.r.l. |
Italy |
| Panzarella, Claudio (ReiThera 202402 Head of Business Development) |
Business Development Manager / Strategy Manager |
ReiThera S.r.l. |
Italy |
| Paracchi, Pierluigi (Genenta Science Srl 201709 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Genenta Science (Group) |
Italy |
| Pasinelli, Francesca (Fondazione Telethon 202006 CEO) |
Chief Executive Officer (CEO) |
Telethon Foundation (Fondazione Telethon) |
Italy |
| Pertile, Paolo (Cutech 201905 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Italy |
| Piazzalunga, Fabio (Menarini 201809 General Manager at Menarini Diagnostics) |
General Manager (management) |
Menarini (Group) |
Italy |
| Pieri, Lidia (Sibylla Biotech 201710– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sibylla Biotech S.p.A. |
Italy |
| Pingue, Claudia (Italy (govt) 202210 Fund Manager at CDP VC Technology Transfer Fund + President at EXTEND) |
Investment Manager |
Italy (govt) |
Italy |
| Polchi, Valentino (Alfatest 201805 General Manager) |
General Manager (management) |
Alfatest (IT) |
Italy |
| Pradella, Lorenzo (GreenBone 201706 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
GreenBone Ortho S.r.l. |
Italy |
| Puglisi, Pietro (Claris Ventures 201907 Managing Partner + Co-Founder) |
Managing Partner (investment firm) |
Claris Ventures (Group) |
Italy |
| Ravagnan, Luca (Wise Srl 202010 CEO) |
Chief Executive Officer (CEO) |
Wise (Group) |
Italy |
| Recordati, Andrea (Recordati 201309– COO) |
Chief Operating Officer (COO) |
Recordati (Group) |
Italy |
| Recordati, Giovanni (Recordati 200810 CEO) |
Chief Executive Officer (CEO) |
Recordati (Group) |
Italy |
| Regonini, Barbara (Genenta Science 202109– Financial Director before OAM + KREnergy SpA + PriceWaterhousCoopers SpA) |
Financial Manager (CFO, Financial Director, etc.) |
Genenta Science (Group) |
Italy |
| Resmini, Enrico (Italy (govt) 202107 CEO of CDP Venture Capital SGR) |
Chief Executive Officer (CEO) |
Italy (govt) |
Italy |
| Ribezzo, Daniela (GFBiochemicals 201509– Global Business Development Manager before Polyscope + Dow Corning) |
Business Development Manager / Strategy Manager |
GFBiochemicals (Group) |
Italy |
| Rizzardi, Paolo (Alltheia Science 201809 CEO) |
Chief Executive Officer (CEO) |
Altheia Science S.r.l. |
Italy |
| Rizzo, Giovanni (Indaco Venture 202403 Partner at Indaco Bio Fund) |
Partner (venture partner) |
Indaco Venture (Group) |
Italy |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
